A detailed history of Harbor Capital Advisors, Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Harbor Capital Advisors, Inc. holds 4,401 shares of DXCM stock, worth $352,256. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,401
Previous 15,702 71.97%
Holding current value
$352,256
Previous $1.78 Million 83.43%
% of portfolio
0.01%
Previous 0.14%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$64.0 - $116.06 $723,264 - $1.31 Million
-11,301 Reduced 71.97%
4,401 $295,000
Q2 2024

Jul 09, 2024

BUY
$110.31 - $140.45 $199,881 - $254,495
1,812 Added 13.05%
15,702 $1.78 Million
Q1 2024

May 13, 2024

SELL
$114.22 - $140.1 $57,795 - $70,890
-506 Reduced 3.51%
13,890 $1.93 Million
Q4 2023

Jan 08, 2024

BUY
$75.49 - $124.16 $61,977 - $101,935
821 Added 6.05%
14,396 $1.79 Million
Q3 2023

Oct 20, 2023

BUY
$86.06 - $137.93 $183,652 - $294,342
2,134 Added 18.65%
13,575 $1.27 Million
Q2 2023

Jul 11, 2023

SELL
$112.47 - $130.98 $478,559 - $557,319
-4,255 Reduced 27.11%
11,441 $1.47 Million
Q1 2023

Apr 26, 2023

BUY
$104.0 - $122.92 $714,896 - $844,952
6,874 Added 77.92%
15,696 $1.82 Million
Q4 2022

Jan 20, 2023

SELL
$84.98 - $122.67 $16,146 - $23,307
-190 Reduced 2.11%
8,822 $0
Q3 2022

Oct 28, 2022

SELL
$76.35 - $94.18 $76,044 - $93,803
-996 Reduced 9.95%
9,012 $726,000
Q2 2022

Jul 26, 2022

BUY
$67.99 - $132.89 $504,961 - $986,974
7,427 Added 287.76%
10,008 $746,000
Q1 2022

Apr 28, 2022

BUY
$94.08 - $130.2 $5,362 - $7,421
57 Added 2.26%
2,581 $1.32 Million
Q4 2021

Feb 04, 2022

BUY
$129.87 - $162.82 $327,791 - $410,957
2,524 New
2,524 $1.36 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.9B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Harbor Capital Advisors, Inc. Portfolio

Follow Harbor Capital Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbor Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbor Capital Advisors, Inc. with notifications on news.